• / Free eNewsletters & Magazine
  • / My Account
Home>European Commission

European Commission

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Medivir: Interim Report, January – June 2014*

    Medivir: Interim Report, January – June 2014*

  2. UPDATE: Euro-zone spin doctors speechless as GDP sinks

    UPDATE: Euro-zone spin doctors speechless as GDP sinks

  3. European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

    European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

  4. European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A

    European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A

  5. UPDATE: EU, Russia and Ukraine to hold talks on gas supplies, trade

    UPDATE: EU, Russia and Ukraine to hold talks on gas supplies, trade

  6. Russia, Ukraine, EU to Hold Talks on Gas, Trade

    Russia, Ukraine, EU to Hold Talks on Gas, Trade

  7. EU, Russia and Ukraine to hold talk on gas supplies, trade

    EU, Russia and Ukraine to hold talk on gas supplies, trade

  8. Array of Stellar Keynote Speakers Confirmed for IBC2014 Conference

    Array of Stellar Keynote Speakers Confirmed for IBC2014 Conference

  9. ECSEL JU Kick-Starts Synergies between European Policies with 40 Billion Euro Total Funding in 2014

    ECSEL JU Kick-Starts Synergies between European Policies with 40 Billion Euro Total Funding in 2014

  10. Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala

    Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.